HIV and Global Cardiovascular Health
- PMID: 35802233
- DOI: 10.1007/s11886-022-01741-1
HIV and Global Cardiovascular Health
Abstract
Purpose of review: Because of effective combination antiretroviral therapy, people living with HIV (PLWH) are living longer but developing chronic age-related conditions including cardiovascular disease (CVD), the leading cause of death globally. This review aims to discuss the epidemiology, mechanisms, and clinical considerations of CVD in PLWH from a global perspective.
Recent findings: PLWH are at greater risk for CVD at chronologically younger ages than those without HIV. Potential underlying mechanisms for CVD in PLWH include systemic inflammation, comorbidities, immune-mediated, or treatment-related mechanisms. There is also risk factor variation based on geographical location, including non-traditional CVD risk factors. CVD is prevalent in PLWH and increasing on a global scale. Further understanding the unique epidemiology, risk factors, and treatment of CVD in this population will improve the care of PLWH.
Keywords: ASCVD; Antiretrovial therapy; Cardiovascular disease; HIV; PLWH.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
Papers of particular interest, published recently, have been highlighted as: •• Of major importance
-
- CONFRONTING INEQUALITIES: Lessons for pandemic responses from 40 years of AIDS [Internet]. GLOBAL AIDS UPDATE 2021; Available from: https://www.unaids.org/sites/default/files/media_asset/2021-global-aids-...
-
- Schouten J, Wit FW, Stolte IG, Kootstra NA, van der Valk M, Geerlings SE, et al. Cross-sectional comparison of the prevalence of age-associated comorbidities and their risk factors between HIV-infected and uninfected individuals: the AGEhIV cohort study. Clin Infect Dis. 2014;59:1787–97.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
